Operating Lease, Liability, Current of REGENERON PHARMACEUTICALS, INC. from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
REGENERON PHARMACEUTICALS, INC. quarterly Operating Lease, Liability, Current in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • REGENERON PHARMACEUTICALS, INC. Operating Lease, Liability, Current for the quarter ending 31 Dec 2024 was $30,300,000, a 59% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

REGENERON PHARMACEUTICALS, INC. Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $30,300,000 +$11,300,000 +59% 31 Dec 2024 10-K 05 Feb 2025 2024 FY
Q4 2023 $19,000,000 +$6,600,000 +53% 31 Dec 2023 10-K 05 Feb 2025 2024 FY
Q4 2022 $12,400,000 31 Dec 2022 10-K 05 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.